Millipore Sigma Vibrant Logo

196878 (±)-Bay K 8644 - CAS 93468-89-4 - Calbiochem

Descripción

Replacement Information

Tabla espec. clave

CAS #Empirical Formula
93468-89-4C₁₆H₁₅F₃N₂O₄

Precios y disponibilidad

Número de referencia DisponiblidadEmbalaje Cant./Env. Precio Cantidad
196878-1MG
Comprobando disponibilidad...
Disponibilidad a confirmar
Disponibilidad a confirmar
Ingrese cantidad 
Suspendido
Cantidades limitadas disponibles
Debe confirmarse disponibilidad
    El resto: se avisará
      El resto: se avisará
      Se avisará
      Póngase en contacto con el Servicio de Atención al Cliente
      Contact Customer Service

      Ampolla de plást. 1 mg
      Recuperando precio...
      No pudo obtenerse el precio
      La cantidad mínima tiene que ser múltiplo de
      Maximum Quantity is
      Al finalizar el pedido Más información
      Ahorró ()
       
      Solicitar precio
      Description
      OverviewSynthetic dihydropyridine derivative that acts as an active Ca2+ slow channel agonist in neuroendocrine, muscle, thyroid and other cell types. Prolongs single channel open time without affecting the close time. An L-type Ca2+ channel agonist. Composed of two optical isomers. The (-)-enantiomer has strong vasoconstrictive, positive inotropic, and Ca2+ agonistic properties, whereas the (+)-enantiomer has weakly vasodilating, negative inotropic, and Ca2+ antagonistic properties. The net effect of the racemic mix is that of the negative enantiomer. Promotes β-cell proliferation/regeneration.
      Catalogue Number196878
      Brand Family Calbiochem®
      Synonyms1,4-Dihydro-2,6-dimethyl-5-nitro-4-[2ʹ-(trifluoromethyl)phenyl]-3-pyridinecarboxylic Acid Methyl Ester
      References
      ReferencesWang, W., et al. 2009. Proc. Natl. Acad. Sci. USA 106, 1427.
      Weigl, L.G., et al. 2000. J. Physiol. 525 (pt. 2), 461.
      Vannier, C., et al. 1995. Am. J. Physiol. 268, L201.
      Bechem, M., and Hoffmann, H. 1993. Pflugers Arch. 424, 343.
      Triggle, D.J., and Rompe, D. 1989. Trends Pharmacol. Sci. 10, 507.
      Takasu, N., et al. 1987. Biochem. Biophys. Res. Commun. 143, 1107.
      Tagliatela, M., et al. 1986. Brain Res. 381, 356.
      Franckowiak, G., et al. 1985. Eur. J. Pharmacol. 114, 223.
      Product Information
      CAS number93468-89-4
      ATP CompetitiveN
      FormYellow solid
      Hill FormulaC₁₆H₁₅F₃N₂O₄
      Chemical formulaC₁₆H₁₅F₃N₂O₄
      ReversibleN
      Structure formula ImageStructure formula Image
      Quality LevelMQ100
      Applications
      Biological Information
      Primary TargetL-type Ca2+ channel
      Purity≥98% by HPLC
      Physicochemical Information
      Cell permeableN
      Dimensions
      Materials Information
      Toxicological Information
      Safety Information according to GHS
      Safety Information
      R PhraseR: 36/38

      Irritating to eyes and skin.
      S PhraseS: 26-36

      In case of contact with eyes, rinse immediately with plenty of water and seek medical advice.
      Wear suitable protective clothing.
      Product Usage Statements
      Storage and Shipping Information
      Ship Code Ambient Temperature Only
      Toxicity Irritant
      Storage +2°C to +8°C
      Protect from Light Protect from light
      Do not freeze Ok to freeze
      Special InstructionsFollowing reconstitution, store in the refrigerator (4°C). Stock solutions are stable for up to 20 days at 4°C.
      Packaging Information
      Transport Information
      Supplemental Information
      Specifications
      Global Trade Item Number
      Número de referencia GTIN
      196878-1MG 04055977206609

      Documentation

      (±)-Bay K 8644 - CAS 93468-89-4 - Calbiochem Ficha datos de seguridad (MSDS)

      Título

      Ficha técnica de seguridad del material (MSDS) 

      (±)-Bay K 8644 - CAS 93468-89-4 - Calbiochem Certificados de análisis

      CargoNúmero de lote
      196878

      Referencias bibliográficas

      Visión general referencias
      Wang, W., et al. 2009. Proc. Natl. Acad. Sci. USA 106, 1427.
      Weigl, L.G., et al. 2000. J. Physiol. 525 (pt. 2), 461.
      Vannier, C., et al. 1995. Am. J. Physiol. 268, L201.
      Bechem, M., and Hoffmann, H. 1993. Pflugers Arch. 424, 343.
      Triggle, D.J., and Rompe, D. 1989. Trends Pharmacol. Sci. 10, 507.
      Takasu, N., et al. 1987. Biochem. Biophys. Res. Commun. 143, 1107.
      Tagliatela, M., et al. 1986. Brain Res. 381, 356.
      Franckowiak, G., et al. 1985. Eur. J. Pharmacol. 114, 223.
      Ficha técnica

      Note that this data sheet is not lot-specific and is representative of the current specifications for this product. Please consult the vial label and the certificate of analysis for information on specific lots. Also note that shipping conditions may differ from storage conditions.

      Revision02-February-2009 JSW
      Synonyms1,4-Dihydro-2,6-dimethyl-5-nitro-4-[2ʹ-(trifluoromethyl)phenyl]-3-pyridinecarboxylic Acid Methyl Ester
      DescriptionA synthetic dihydropyridine derivative that is an active Ca2+ slow channel agonist in neuroendocrine, muscle, thyroid, and other cell types. Prolongs single channel open time without affecting the close time. An L-type Ca2+ channel agonist. Composed of two optical isomers. The (-)-enantiomer has strong vasoconstrictive, positive ionotropic, and Ca2+ agonistic properties, whereas the (+)-enantiomer has weak vasodilating, negative ionotropic, and Ca2+ antagonistic properties. The net effect of the racemic mix is that of the negative enantiomer. Promotes β-cell proliferation/regeneration.
      FormYellow solid
      CAS number93468-89-4
      Chemical formulaC₁₆H₁₅F₃N₂O₄
      Structure formulaStructure formula
      Purity≥98% by HPLC
      SolubilityEthanol (35 mg/ml) or DMSO (35 mg/ml)
      Storage Protect from light
      +2°C to +8°C
      Do Not Freeze Ok to freeze
      Special InstructionsFollowing reconstitution, store in the refrigerator (4°C). Stock solutions are stable for up to 20 days at 4°C.
      Toxicity Irritant
      ReferencesWang, W., et al. 2009. Proc. Natl. Acad. Sci. USA 106, 1427.
      Weigl, L.G., et al. 2000. J. Physiol. 525 (pt. 2), 461.
      Vannier, C., et al. 1995. Am. J. Physiol. 268, L201.
      Bechem, M., and Hoffmann, H. 1993. Pflugers Arch. 424, 343.
      Triggle, D.J., and Rompe, D. 1989. Trends Pharmacol. Sci. 10, 507.
      Takasu, N., et al. 1987. Biochem. Biophys. Res. Commun. 143, 1107.
      Tagliatela, M., et al. 1986. Brain Res. 381, 356.
      Franckowiak, G., et al. 1985. Eur. J. Pharmacol. 114, 223.